Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.6000
+0.0100 (1.69%)
Nov 20, 2026, 1:42 PM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 41.99 million as of November 20, 2026. It is the 33,519th most valuable company in the world and the 925th biggest in Canada. Its market cap has increased by 24.62% in one year.
Market Cap
41.99M
Enterprise Value
34.71M
Revenue
n/a
Global Rank
Country Rank
#925 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 41.99M, an increase of 200.88%. That is a compound annual growth rate of 27.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 41.99M | 24.62% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 68.74M |
| NurExone Biologic | 47.23M |
| Sharp Therapeutics | 43.26M |
| BriaCell Therapeutics | 40.65M |
| Microbix Biosystems | 40.41M |
| MedMira | 38.60M |
| Sernova Biotherapeutics | 33.99M |
| Sona Nanotech | 31.93M |